ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

290 hedge funds and large institutions have $9.06B invested in Alnylam Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 110 increasing their positions, 88 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
290
Holders Change
+7
Holders Change %
+2.47%
% of All Funds
6.29%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.26%
New
35
Increased
110
Reduced
88
Closed
28
Calls
$82.4M
Puts
$52.5M
Net Calls
+$29.9M
Net Calls Change
-$40.2M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$87.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$73.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$41.1M
5
MC
Maverick Capital
Texas
+$38M

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$43.7M
2
UBS AM
UBS AM
Illinois
-$24.2M
3
PA
Perceptive Advisors
New York
-$18.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$18M
5
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
-$17.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.49B +$73.9M +791,113 +5%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.39B +$71.6M +766,371 +5%
Vanguard Group
3
Vanguard Group
Pennsylvania
$809M +$41.1M +439,757 +5%
BlackRock
4
BlackRock
New York
$601M +$26.4M +282,322 +5%
Baillie Gifford & Co
5
Baillie Gifford & Co
United Kingdom
$531M +$87.6M +937,654 +20%
Dodge & Cox
6
Dodge & Cox
California
$467M +$28.8M +307,750 +7%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$326M -$18M -192,236 -5%
MC
8
Maverick Capital
Texas
$300M +$38M +406,436 +14%
State Street
9
State Street
Massachusetts
$257M +$32.1M +343,759 +14%
BB
10
BB Biotech
Switzerland
$152M +$5.58M +59,700 +4%
Morgan Stanley
11
Morgan Stanley
New York
$114M +$3.5M +37,462 +3%
First Trust Advisors
12
First Trust Advisors
Illinois
$111M +$1.35M +14,439 +1%
UBS AM
13
UBS AM
Illinois
$108M -$24.2M -259,352 -18%
Norges Bank
14
Norges Bank
Norway
$107M -$13.6M -145,507 -11%
Goldman Sachs
15
Goldman Sachs
New York
$95M -$9.57M -102,375 -9%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$94M +$8.47M +90,689 +10%
GGHC
17
Gilder Gagnon Howe & Co
New York
$92.3M +$3.1M +33,174 +3%
RI
18
RTW Investments
New York
$78.1M +$37M +396,375 +90%
1WCM
19
12 West Capital Management
New York
$68.7M – – –
American Century Companies
20
American Century Companies
Missouri
$66.4M +$1.65M +17,687 +3%
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
$60.9M +$19.3M +206,129 +46%
PAMU
22
Pictet Asset Management (UK)
United Kingdom
$58.8M -$4.82M -51,631 -8%
BM
23
Bridger Management
New York
$58.2M -$3.4M -36,335 -6%
Northern Trust
24
Northern Trust
Illinois
$52.2M +$2.49M +26,657 +5%
Federated Hermes
25
Federated Hermes
Pennsylvania
$49.3M +$84.1K +900 +0.2%
1
2 3 4 5